Lacrimal epithelium mediates hormonal influences on antigen-presenting cells and lymphocyte cycles in the ocular surface system

Antigen-Presenting Cells and the Eye

Volumn , Issue , 2007, Pages 93-120

  Mircheff, Austin K ^a   Wang, Yanru ^a   de Saint Jean, Magdalena Baladud ^a   Ding, Chuanqing ^a   Schechter, Joel E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649915327     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (196)

1. Franklin RM, Kenyon KR, Tomasi TB Jr. Immunohistologic studies of human lacrimal gland: localization of immunoglobulins, secretory component, and lactoferrin. J Immunol 1973; 984-992.
2. Franklin RM, Prendergast RA, Silverstein AM. Secretory immune system of rabbit ocular adnexa. Invest Ophthalmol Vis Sci. 1979; 18: 1093-1096.
3. Franklin RM, Remus, LE. Conjunctival-associated lymphoid tissue: evidence for a role in the secretory immune system. Invest Ophthalmol Vis Sci 1984; 25: 181-187
4. Allansmith MR, Kajiyama G, Abelson MB, Simon MA. Plasma cell content of main and accessory lacrimal glands and conjunctiva. Am J Ophthalmol 1976; 82: 819-826.
5. Chodosh J, Nordquist RE, Kennedy RC. Comparative anatomy of mammalian conjunctival lymphoid tissue, a putative mucosal immune site. Dev Comp Immunol 1998; 22: 621-630.
6. Knop N, Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest Opthalmol Vis Sci. 2000; 41: 1270-1279.
7. Knop E, Knop N. Lacrimal drainage-associated lymphoid tissue (LDALT): a part of the human mucosal immune system. Invest Ophthalmol Vis Sci 2001; 42: 566-574.
8. Paulsen FP, Paulsen JI, Thale AB, Tillmann BN. Mucosa-associated lymphoid tissue in human efferent tear ducts. Virchows Arch 2000; 437: 185-189.
9. Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci U S A 1991; 88: 8796-8800.
10. Wolf HM, Hauber I, Gulle H, et al. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and FcαR (CD89)-mediated downregulation of tumour necrosis factor-alpha (TNF-α) and IL-6 in human monocytes. Clin Exp Immunol 1996; 105: 537-543.
11. Wolf HM, Fischer MB, Puhringer H, Samstag A, Vogel E, Eibl MM. Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factoralpha, interleukin-6) in human monocytes. Blood 1994; 83: 1278-1288.
12. Kvale D, Lovhaug D, Sollid LM, Brandtzaeg P. Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol 1988; 140: 3086-3089.
13. Wieczorek R, Jakobiec FA, Sacks EH, Knowles DM. The immunoarchitecture of the normal human lacrimal gland. Relevancy for understanding pathologic conditions. Ophthalmology 1988; 95: 100-109.
14. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren’s syndrome. J Clin Invest 1998; 102: 938-946.
15. Xanthou G, Tapinos NI, Polihronis M, Nezis IP, Margaritis LH, Moutsopoulos HM. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren’s syndrome. Clin Exp Immunol 1999; 118: 154-163.
16. Amft N, Curnow SJ, Scheel-Toellner D, et al. Ectopic expression of the B cellattracting chemokine BCA-1 (CXCL 13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren’s syndrome. Arthritis Rheum 2001; 44: 2633-2641.
17. Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren’s syndrome. Arthritis Rheum 2003; 48: 3187-3201.
18. Ogawa Y, Kuwana M, Yamazaki K, et al. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003; 44: 1888-1896.
19. Schechter J, Carey J, Wallace M, Wood R. Distribution of growth factors and immune cells are altered in the lacrimal gland during pregnancy and lactation. Exp Eye Res 2000; 71: 129-142.
20. Damato BE, Allan D, Murray SB, Lee WR. Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease. Br J Ophthalmol 1984; 68: 674-680.
21. Kuhn LC, Kraehenbuhl JP. Role of secretory component, a secreted glycoprotein, in the specific uptake of IgA dimer by epithelial cells. J Biol Chem 1979; 254: 11072-11081.
22. Mostov KE, Deitcher DL. Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA. Cell 1986; 46: 613-621.
23. Qian L, Wang Y, Xie J, et al. Biochemical changes contributing to functional quiescence in lacrimal gland acinar cells after chronic ex vivo exposure to a muscarinic agonist. Scand J Immunol 2003; 58: 550-565.
24. Wang Y, Jerdeva G, Yarber FA, et al. Cytoplasmic dynein participates in apically targeted stimulated secretory traffic in primary rabbit lacrimal acinar epithelial cells. J Cell Sci 2003; 116: 2051-2065.
25. Farquhar MG. Membrane recycling in secretory cells: implications for traffic of products and specialized membranes within the Golgi complex. Methods Cell Biol 1981; 23: 399-427.
26. Nimmerjahn F, Milosevic S, Behrends U, et al. Major histocompatibility complex class II-restricted presentation of cytosolic antigen by autophagy. Eur J Immunol 2003; 33: 1250-1259.
27. Yang T, Zeng H, Zhang J, et al. MHC class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes. Am J Physiol 1999; 277: C994-C1007.
28. Hawk RM, Duncan R, Rose CM, Chiu CT, Qian L, Mircheff AK. Intracellular traffic of novel candidate autoimmune dacryoadenitis autoantigens. Ocular Surface 2005; 3: S73.
29. Gierow JP, Lambert RW, Mircheff AK. Fluid phase endocytosis by isolated rabbit lacrimal gland acinar cells. Exp Eye Res 1995; 60: 511-525.
30. Lambert RW, Maves CA, Gierow JP, Wood RL, Mircheff AK. Plasma membrane internalization and recycling in rabbit lacrimal acinar cells. Invest Ophthalmol Vis Sci 1993; 34: 305-316.
31. Yang T, Zeng H, Zhang J, et al. Stimulation with carbachol alters endomembrane distribution and plasma membrane expression of intracellular proteins in lacrimal acinar cells. Exp Eye Res 1999; 69: 651-661.
32. Schechter JE, Stevenson D, Chang D, et al. Growth of purified lacrimal acinar cells in Matrigel® raft cultures. Exp Eye Res 2002; 74: 349-360.
33. Rose CM, Qian L, Hakim L, et al. Accumulation of catalytically active proteases in lacrimal gland acinar cell endosomes during chronic ex vivo muscarinic receptor stimulation. Scand J Immunol 2005; 61: 36-50.
34. Peterson DA, DiPaolo RJ, Kanagawa O, Unanue ER. Cutting edge: negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells. J Immunol 1999; 162: 3117-3120.
35. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11: 729-766.
36. Sercarz EE, Maverakis E. MHC-guided processing: binding of large antigen fragments. Nat Rev Immunol 2003; 3: 621-629.
37. Wolf JL, Bye WA. The membranous epithelial (M) cell and the mucosal immune system. Annu Rev Med 1984; 35: 95-112.
38. Neutra MR, Pringault E, Kraehenbuhl J-P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol 1996; 14: 275-300.
39. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2: 361-367.
40. Montgomery PC, Rockey JH, Majumdar AS, Lemaitre-Coelho IM, Vaerman JP, Ayyildiz A. Parameters influencing the expression of IgA antibodies in tears. Invest Ophthalmol Vis Sci 1984; 25: 369-373.
41. Ridley-Lathers DM, Gill RF, Montgomery PC. Inductive pathways leading to rat tear IgA antibody responses. Invest Ophthalmol Vis Sci. 1998; 39: 1005-1011.
42. Butch AW, Chung GH, Hoffmann JW, Nahm MH. Cytokine expression by germinal center cells. J Immunol 1993; 150: 39-47.
43. Gray D, Kosco M, Stockinger B. Novel pathways of antigen presentation for the maintenance of memory. Int Immunol 1991; 3: 141-148.
44. Calame KL. Plasma cells: finding new light at the end of B cell development. Nat Immunol 2001; 2: 1103-1108.
45. Choe J, Choi YS. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. Eur J Immunol 1998; 28: 508-515.
46. Arpin C, Déchanet J, van Kooten C, et al. Generation of memory B cells and plasma cells in vitro. Science 1995; 268: 720-722.
47. Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989; 170: 1039-1044.
48. Lebman DA, Lee FD, Coffman RL. Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol 1990; 144: 952-959.
49. Kim PH, Kagnoff MF. Transforming growth factor-beta 1 is a costimulator for IgA production. J Immunol 1990; 144: 3411-3416.
50. Chen SS, Li Q. Transforming growth factor-beta 1 (TGF-beta 1) is a bifunctional immune regulator for mucosal IgA responses. Cell Immunol 1990; 128: 353-361.
51. Islam KB, Nilsson L, Sideras P, Hammarstrom L, Smith CI. TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 1991; 3: 1099-1106.
52. Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naïve human B cells to secrete immunoglobulin A. J Exp Med 1992; 175: 671-682.
53. Fujieda S, Waschek JA, Zhang K, Saxon A. Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells. J Clin Invest 1996; 98: 1527-1532.
54. Kimata H, Fujimoto M. Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production. Eur J Immunol 1994; 24: 2262-2265.
55. Schrader CE, George A, Kerlin RL, Cebra JJ. Dendritic cells support production of IgA and other non-IgM isotypes in clonal microculture. Int Immunol 1990; 2: 563-570.
56. Hargreaves DC, Hyman PL, Lu TT, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001: 194: 45-56.
57. Tanneau GM, Hibrand-Saint-Oyant L, Chevaleyre CC, Salmon HP. Differential recruitment of T and IgA B-lymphocytes in the developing mammary gland in relation to homing receptors and vascular addressins. J Histochem Cytochem 1999; 47: 1581-1592.
58. van der Feltz MJ, de Groot N, Bayley JP, Lee SH, Verbeet MP, de Boer HA. Lymphocyte homing and Ig secretion in the murine mammary gland. Scand J Immunol 2001; 54: 292-300.
59. Nakayama T, Hieshima K, Izawa D, Tatsumi Y, Kanamaru A, Yoshie O. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003; 170: 1136-1140.
60. Hieshima K, Kawasaki Y, Hanamoto H, Nakayama T, Nagakubo D, Yoshie O. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J Immunol 2004; 173: 3668-3675.
61. Kelleher RS, Hann LE, Edwards JA, Sullivan DA. Endocrine, neural, and immune control of secretory component output by lacrimal gland acinar cells. J Immunol 1991; 146: 3405-3412.
62. Leiba H, Garty NB, Schmidt-Sole J, Piterman O, Azrad A, Salomon Y. The melanocortin receptor in the rat lacrimal gland: a model system for the study of MSH (melanocyte stimulating hormone) as a potential neurotransmitter. Eur J Pharmacol 1990; 181: 71-82.
63. Uddman R, Alumets J, Ehinger B, Hakanson R, Loren I, Sundler F. Vasoactive intestinal peptide nerves in ocular and orbital structures of the cat. Invest Ophthalmol Vis Sci 1980; 19: 878-885.
64. Sibony PA, Walcott B, McKeon C, Jakobiec FA. Vasoactive intestinal polypeptide and the innervation of the human lacrimal gland. Arch Ophthalmol 1988; 106: 1085-1088.
65. Matsumoto Y, Tanabe T, Ueda S, Kawata M. Immunohistochemical and enzymehistochemical studies of peptidergic, aminergic, and cholinergic innervation of the lacrimal gland of the monkey (Macaca fuscata). J Auton Nerv Syst 1992; 37: 207-214.
66. Ding C, Walcott B, Keyser KT. Neuronal nitric oxide synthase and the autonomic innervation of the mouse lacrimal gland. Invest Ophthalmol Vis Sci 2001; 42: 2789-2794.
67. Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 1995; 85: 487-494.
68. Morse L, Chen D, Franklin D, Xiong Y, Chen-Kiang S. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18INH4c and IL-6. Immunity 1997; 6: 47-56.
69. Beagley KW, Eldridge JH, Lee F, et al. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989; 169: 2133-2148.
70. McGee DW, Aicher WK, Eldridge JH, Peppard JV, Mestecky J, McGhee JR. Transforming growth factor-beta enhances secretory component and major histocompatibility complex class I antigen expression on rat IEC-6 intestinal epithelial cells. Cytokine 1991; 3: 543-550.
71. McGee DW, Beagley KW, Aicher WK, McGhee JR. Transforming growth factor-beta enhances interleukin-6 secretion by intestinal epithelial cells. Immunology 1992; 77: 7-12.
72. Rafferty DE, Montgomery PC. Effects of transforming growth factor beta on immunoglobulin production in cultured rat lacrimal gland tissue fragments. Reg Immunol 1993; 5: 312-316.
73. Rafferty DE, Montgomery PC. The effects of transforming growth factor-beta and interleukins 2, 5 and 6 on immunoglobulin production in cultured rat salivary gland tissues. Oral Microbiol Immunol 1995; 10: 81-86.
74. Palkowetz KH, Royer CL, Garofalo R, Rudloff HE, Schmalstieg FC Jr, Goldman AS. Production of interleukin-6 and interleukin-8 by human mammary gland epithelial cells. J Reprod Immunol 1994; 26: 57-64.
75. Basolo F, Conaldi PG, Fiore L, Calvo S, Toniolo A. Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: defective IL-6 expression in mammary carcinoma. Int J Cancer 1993; 55: 926-930.
76. Chiu JJ, Sgagias MK, Cowan KH. Interleukin-6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 1996; 2: 215-221.
77. Silberstein GB, Flanders KC, Roberts AB, Danial CW. Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta1. Dev Biol 1992; 152: 354-362.
78. Takahashi M, Watari E, Mabuchi A, Yokomuro K. Production of B cell differentiation factors by mouse parenchymal liver cells. Immunol Cell Biol 1997; 75: 575-579.
79. Chedid A, Mendenhall CL, Moritz TE. The antigenic homogeneity of the bile duct in alcoholic liver disease. Arch Pathol Lab Med 1999; 123: 411-414.
80. Eckmann L, Jung HC, Schurer-Maly C, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993; 105: 1689-1697.
81. Aldhous MC, Shmakov AN, Bode J, Ghosh S. Characterization of conditions for the primary culture of human small intestinal epithelial cells. Clin Exp Immunol 2001; 125: 32-40.
82. Denning TL, Campbell NA, Song F, et al. Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int Immunol 2000; 12: 133-139.
83. Hodge S, Hodge G, Flower R, Reynolds PN, Scicchitano R, Holmes M. Upregulation of production of TGF-βand IL-4 and down-regulation of IL-6 by apoptotic human bronchial epithelial cells. Immunol Cell Biol 2002; 80: 537-543.
84. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren’s syndrome keratoconjunctivitis. Curr Eye Res 1999; 19: 201-211.
85. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjogren’s syndrome. J Immunol 1994; 152: 5532-5539.
86. Tapinos NI, Polihronis M, Tzioufas AG, Skopouli FN. Immunopathology of Sjögren’s syndrome. Ann Med Interne (Paris) 1998; 149: 17-24.
87. Sun D, Emmert-Buck MR, Fox PC. Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjögren’s syndrome. Autoimmunity 1998; 28: 125-137.
88. Zhang Y, Xie J, Qian L, Schechter JE, Mircheff AK. IL-2 immunoreactive proteins in lacrimal acinar cells. Adv Exp Med Biol 2002; 506: 795-799.
89. Ding C, Wong J, Mircheff AK, Schechter JE. Myoepithelial cells and neuronal nitric oxide synthase in the rabbit lacrimal gland. Ocular Surface 2005; 3: S57.
90. Beauregard C, Brandt PC, Chiou GC. Induction of nitric oxide synthase and overproduction of nitric oxide by interleukin-1beta in cultured lacrimal gland acinar cells. Exp Eye Res 2003; 77: 109-114.
91. Stern JE, Gardner S, Quirk D, Wira CR. Secretory immune system of the male reproductive tract: effects of dihydrotestosterone and estradiol on IgA and secretory component levels. J Reprod Immunol 1992; 22: 73-85.
92. Parr MA, Ren HP, Russell LD, Prins GS, Parr EL. Urethral glands in the male mouse contain secretory component and immunoglobulin A plasma cells and are targets of testosterone. Biol Reprod 1992; 47: 1031-1039.
93. Sullivan DA, Hann LE. Hormonal influence on the secretory immune system of the eye: endocrine impact on the lacrimal gland accumulation and secretion of IgG and IgA. J Steroid Biochem 1989; 34: 253-262.
94. Gao J, Lambert RW, Wickham LA, Banting G, Sullivan DA. Androgen control of secretory component mRNA levels in the rat lacrimal gland. J Steroid Biochem Mol Biol 1995; 52: 239-249.
95. Weisz-Carrington P, Roux ME, McWilliams M, Phillips-Quagliata JM, Lamm ME. Hormonal induction of the secretory immune system in the mammary gland. Proc Natl Acad Sci U S A 1978; 75: 2928-2932.
96. Rincheval-Arnold A, Belair L, Djiane J. Developmental expression of pIgR gene in sheep mammary gland and hormonal regulation. J Dairy Res 2002; 69: 13-26.
97. Rosato R, Jammes H, Belair L, Puissant C, Kraehenbuhl JP, Djiane J. Polymeric-Ig receptor gene expression in rabbit mammary gland during pregnancy and lactation: evolution and hormonal regulation. Mol Cell Endocrinol 1995; 110: 81-87.
98. Ewan KB, Shyamala G, Ravani SA, et al. Latent transforming growth factor-beta activation in mammary gland. Regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol 2002; 160: 2081-2093.
99. Clevenger CV, Kline JB. Prolactin receptor signal transduction. Lupus 2001; 10: 706-718.
100. Bernadotte F, Mattsson R. A fraction of murine placental extract enhances IgA production in cultured splenocytes. J Reprod Immunol 1992; 21: 189-202.
101. Morales P, Carretero MV, Geronimo H, et al. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ 1999; 10: 583-590.
102. Richards SM, Garman RD, Keyes L, Kavanagh B, McPherson JM. Prolactin is an antagonist of TGF-βactivity and promotes proliferation of murine B cell hybridomas. Cell Immunol 1998; 184: 85-91.
103. Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naïve B cell repertoire. J Clin Invest 2003; 111: 275-283.
104. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480-483.
105. Maric I, Holt PG, Perdue MH, Bienenstock J. Class II MHC antigen (Ia)-bearing dendritic cells in the epithelium of the rat intestine. J Immunol 1996; 156: 1408-1414.
106. Stumbles PA, Upham JW, Holt PG. Airway dendritic cells: co-ordinators of immunological homeostasis and immunity in the respiratory tract. APMIS 2003; 111: 741-755.
107. Woo J, Lu L, Rao AS, et al. Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation 1994; 58: 484-491.
108. Abe M, Akbar SM, Horiike N, Onji M. Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 2001; 34: 61-67.
109. Stasulis CA, Hand AR. Immunohistochemical identification of antigen presenting cells in rat salivary glands. Arch Oral Biol 2003; 48: 691-699.
110. van Blokland SC, van Helden-Meeuwsen CG, Wierenga-Wolf AF, et al. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjogren’s syndrome: a differential role for dendritic cells in the initiation of sialoadenitis? Lab Invest 2000; 80: 575-585.
111. Gomes JAP, Jindal VK, Gormley PD, Dua HS. Phenotypic analysis of resident lymphoid cells in the conjunctiva and adnexal tissues of rat. Exp Eye Res 1997; 64: 991-997.
112. Sacks E, Rutgers J, Jakobiec FA, Bonetti F, Knowles DM. A comparison of conjunctival and nonocular dendritic cells utilizing new monoclonal antibodies. Ophthalmology 1986; 93: 1089-1097.
113. Hamrah P, Liu Y, Zhang Q, Dana MR. Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol 2003; 121: 1132-1140.
114. Novak N, Siepmann K, Zierhut M, Bieber T. The good, the bad and the ugly - APCs of the eye. Trends Immunol 2003; 24: 570-574.
115. Huang FP, Platt N, Wykes M, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000; 191: 435-444.
116. Scheinecker C, McHugh R, Shevach EM, Germain RN. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med 2002; 196: 1079-1090.
117. Albert ML, Pearce SF, Francisco LM, et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998; 188: 1359-1368.
118. Matsuno K, Ezaki T, Kudo S, Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med 1996; 183: 1865-1878.
119. Alpan O, Rudomen G, Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 2001; 166: 4843-4852.
120. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985; 161: 526-546.
121. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994; 179: 1109-1118.
122. Inaba K, Witmer-Pack M, Inaba M, et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994; 180: 1849-1860.
123. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389-400.
124. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423-434.
125. Süss G, Shortman K. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 1996; 183: 1789-1796.
126. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411-416.
127. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769-779.
128. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bharwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001; 193: 233-238.
129. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001; 22: 394-400.
130. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum Immunol 2002; 63: 1156-1163.
131. Nouri-Shirazi M, Guinet E. Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation 2002; 74: 1035-1044.
132. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213-1222.
133. + T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments. Cell Immunol 2002; 215: 186-194.
134. Becker JC, Czerny CC, Bröcker EB. Maintenance of clonal anergy by endogenously produced IL-10. Int Immunol 1994; 6: 1605-1612.
135. Stumbles PA, Thomas JA, Pimm CL, et al. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998; 188: 2019-2031.
136. Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725-731.
137. Akdis CA, Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001; 103: 131-136.
138. Groux H. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003; 75: 8S-12S.
139. Tlaskalová-Hogenová H, Tučková L, Lodinová-Źádniková R, et al. Mucosal immunity: Its role in defense and allergy. Int Arch Allergy Immunol 2002; 128: 77-89.
140. Akbari O, Stock P, DeKruyff RH, Umetsu DT. Mucosal tolerance and immunity: regulating the development of allergic disease and asthma. Int Arch Allergy Immunol 2003; 130: 108-118.
141. Viney JL, Mowat AM, O’Malley JM, Williamson E, Fanger NA. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998; 160: 5815-5825.
142. Yasui H, Ohwaki M. Dose-dependent induction of immunologic enhancement and suppression after oral administration of antigen. Microbiol Immunol 1983; 27: 1107-1116.
143. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-1240.
144. Weiner HL. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207-214.
145. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-βpositively regulates its own production. J Immunol 1998; 160: 5719-5728.
146. Spahn TW, Weiner HL, Rennert PD, et al. Mesenteric lymph nodes are critical for the induction of high dose oral tolerance in the absence of Peyer’s patches. Eur J Immunol 2002; 32: 1109-1113.
147. Kezuka T, Streilein JW. Analysis of in vitro regulatory properties of T cells activated in vivo by TGF-beta2-treated antigen presenting cells. Invest Ophthalmol Vis Sci 2000; 41: 1410-1421.
148. Takeuchi M, Alard P, Streilein JW. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol 1998; 160: 1589-1597.
149. D’Orazio TJ, Niederkorn JY. A novel role for TGF-βand IL-10 in the induction of immune privilege. J Immunol 1998; 160: 2089-2098.
150. Streilein JW, Masli S, Takeuchi M, Kezuka T. The eye’s view of antigen presentation. Hum Immunol 2002; 63: 435-443.
151. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311-1318.
152. +CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 2004; 172: 5213-5221.
153. Modigliani Y, Coutinho A, Pereira P, et al. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur J Immunol 1996; 26: 1807-1815.
154. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160: 1212-1218.
155. +25+ immunoregulatory T cells. J Exp Med 2001; 194: 427-438.
156. Karp CL. Measles: immunosuppression, interleukin-12, and complement receptors. Immunol Rev 1999; 168: 91-101.
157. Jang S, Uematsu S, Akira S, Salgame P. IL-6 and IL-10 induction from dendritic cells in response to mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J Immunol 2004; 173: 3392-3397.
158. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53: 1602-1609.
159. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13: 251-276.
160. Hfarizi H, Juzan M, Pitard V, Moreau JF, Gualde N. Cyclooxygenase-2-issued prostaglandin E2 enhances the production of endogenous IL-10, which downregulates dendritic cell function. J Immunol 2002; 168: 2255-2263.
161. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells. J Immunol 1997; 158: 2919-2925.
162. Winzler C, Rovere P, Rescigno M, et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997; 185: 317-328.
163. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
164. Todryk S, Melcher AA, Hardwick N, et al. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic precursors to enhance antigen uptake. J Immunol 1999; 163: 1398-1408.
165. Brossart P, Zobywalski A, Grünebach F, et al. Tumor necrosis factor α and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res 2000; 60: 4485-4492.
166. Czapiga M, Kirk AD, Lekstrom-Himes J. Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation. Exp Hematol 2004; 32: 135-139.
167. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology 1983; 6: 231-243.
168. Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 1988; 239: 401-404.
169. Matera L, Galetto A, Geuna M, et al. Individual and combined effect of granulocytemacrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. Immunology 2000; 100: 29-36.
170. Matera L, Mori M, Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus 2001; 10: 728-734.
171. Carreño PC, Jiménez E, Sacedón R, Vicente A, Zapata AG. Prolactin stimulates maturation and function of rat thymic dendritic cells. J NeuroImmunol 2004; 153: 83-90.
172. DeVito WJ, Avakian C, Stone S, Okulicz WC, Tang KT, Shamgochian M. Prolactin induced expression of interleukin-1 alpha, tumor necrosis factor-alpha, and transforming growth factor-alpha in cultured astrocytes. J Cell Biochem 1995; 57: 290-298.
173. Mukherjee P, Mastro AM, Hymer WC. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 1990; 126: 88-94.
174. Viselli SM, Stanek EM, Mukherjee P, Hymer WC, Mastro AM. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 1991; 129: 983-990.
175. Dimitrov S, Lange T, Fehm HL, Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav Immun 2004; 18: 368-374.
176. Matera L, Mori M. Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-γ by natural killer and T cells. Ann NY Acad Sci 2000; 917: 505-513.
177. Matera L, Beltramo E, Martinuzzi E, Buttiglieri S. Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells. Clin Exp Immunol 2004; 137: 320-328.
178. Guschchin GV, Cheney C, Glaser R, Malarkey WB. Temporal relationships and IL-2 dependency of prolactin-induced lymphocyte proliferation. J NeuroImmunol 1995; 60: 93-98.
179. Yu-Lee LY. Stimulation of interferon regulatory factor-1 by prolactin. Lupus 2001; 10: 691-699.
180. Akpek EK, Jabs DA, Gérard HC, et al. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci 2004; 45: 185-190.
181. Krishnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology 2003; 144: 2102-2110.
182. Buckley AR, Buckley DJ, Leff MA, Hoover DS, Magnuson NS. Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology 1995; 136: 5252-5259.
183. Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax, by prolactin in rat Nb2 lymphoma cells. Endocrinology 1996; 137: 5456-5462.
184. Törnwall J, Lane TE, Fox RI, Fox HS. T cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice. Lab Invest 1999; 79: 1719-1726.
185. Schuerer-Maly CC, Eckmann L, Kagnoff MF, Falco MT, Maly FE. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 1994; 81: 85-91.
186. Jung HC, Eckmann L, Yang SK, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55-65.
187. Yamano S, Atkinson JC, Baum BJ, Fox PC. Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin Immunol 1999; 92: 265-275.
188. Barka T, van der Noen H. Lack of expression of T-kininogen gene in the hearts of untreated and turpentine injected rats. Life Sci 1994; 54: 1365-1375.
189. Chao J, Swain C, Chao S, Xiong W, Chao L. Tissue distribution and kininogen gene expression after acute-phase inflammation. Biochim Biophys Acta 1988; 964: 329-339.
190. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77: 1033-1079.
191. Wei W, Parvin N, Tsumura K, et al. Induction of C-reactive protein, serum amyloid P component, and kininogens in the submandibular and lacrimal glands of rats with experimentally induced inflammation. Life Sci 2001; 69: 359-368.
192. Philips N, McFadden K. Inhibition of transforming growth factor-beta and matrix metalloproteinases by estrogen and prolactin in breast cancer cells. Cancer Lett 2004; 206: 63-68.
193. Coya R, Alvarez CV, Perez F, Gianzo C, Diéguez C. Effects of TGF-beta1 on prolactin synthesis and secretion: an in vitro study. J Neuroendocrinol 1999; 11: 351-360.
194. Kubota T, Taguchi M, Kobayashi K, Masuda M, Aso T. Relationship between the release of prolactin and endothelin-1 in human decidualized endometrial cells. Eur J Endocrinol 1997; 137: 200-204.
195. Delidow BC, Billis WM, Agarwal P, White BA. Inhibition of prolactin gene transcription by transforming growth factor-beta in GH3 cells. Mol Endocrinol 1991; 5: 1716-1722.
196. Ding C, Wang Y, Zhu Z, et al. Pregnancy and the lacrimal gland: Where have all the hormones gone? Assoc Res Vis Ophthalmol 2005; Abstract 4416.